Correlation Between Tscan Therapeutics and STORE
Specify exactly 2 symbols:
By analyzing existing cross correlation between Tscan Therapeutics and STORE CAP P, you can compare the effects of market volatilities on Tscan Therapeutics and STORE and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tscan Therapeutics with a short position of STORE. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tscan Therapeutics and STORE.
Diversification Opportunities for Tscan Therapeutics and STORE
0.54 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Tscan and STORE is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Tscan Therapeutics and STORE CAP P in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on STORE CAP P and Tscan Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tscan Therapeutics are associated (or correlated) with STORE. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of STORE CAP P has no effect on the direction of Tscan Therapeutics i.e., Tscan Therapeutics and STORE go up and down completely randomly.
Pair Corralation between Tscan Therapeutics and STORE
Given the investment horizon of 90 days Tscan Therapeutics is expected to generate 5.88 times more return on investment than STORE. However, Tscan Therapeutics is 5.88 times more volatile than STORE CAP P. It trades about 0.06 of its potential returns per unit of risk. STORE CAP P is currently generating about 0.0 per unit of risk. If you would invest 190.00 in Tscan Therapeutics on September 5, 2024 and sell it today you would earn a total of 259.00 from holding Tscan Therapeutics or generate 136.32% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 79.6% |
Values | Daily Returns |
Tscan Therapeutics vs. STORE CAP P
Performance |
Timeline |
Tscan Therapeutics |
STORE CAP P |
Tscan Therapeutics and STORE Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Tscan Therapeutics and STORE
The main advantage of trading using opposite Tscan Therapeutics and STORE positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tscan Therapeutics position performs unexpectedly, STORE can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in STORE will offset losses from the drop in STORE's long position.Tscan Therapeutics vs. Apellis Pharmaceuticals | Tscan Therapeutics vs. Iteos Therapeutics | Tscan Therapeutics vs. Day One Biopharmaceuticals | Tscan Therapeutics vs. Acumen Pharmaceuticals |
STORE vs. Catalyst Pharmaceuticals | STORE vs. Casio Computer Co | STORE vs. Paysafe | STORE vs. Tscan Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |